Nick Norwitz MD PhD@nicknorwitz
This article came out in @Telegraph this morning, and it’s already gaining significant traction, apparently reaching top three on the site within hours or release.
telegraph.co.uk/health-fitness…
There’s clearly a lot of engagement, so since I won’t be able to respond to every comment, I want to clarify a few things upfront.
First, I am not, nor have I ever been, anti-pharmacotherapy. What I am against is a lack of nuance. I don’t believe it’s my place to say something as simplistic as “X drug is overprescribed,” (some editorial liberties were taken). However, my concern is that they are prescribed without sufficient individualization and thoughtfulness.
My critique is not of pharmaceuticals themselves, but of a system that too often operates algorithmically, rather than with the precision each patient deserves.
Having personally experienced the downsides of that kind of care (multiple times), I feel comfortable speaking to it with the authority of a patient, MD PhD or not.
Second, I did not request, solicit, or pay for this article in any way. I was approached for it just as I was for an upcoming lecture at the @UniofOxford Longevity Summit, hosted at Rhodes House this weekend. I did no approaching, nor do I get any sort of kickbacks.
Third, this is not an article I wrote, nor is it intended to be an academic dissertation. If you’re looking for deeper nuance, I’d encourage you to explore my broader body of work, on YouTube or through my Substack, which covers dozens of articles on heart health and synthesizes hundreds of studies and human trials.
staycuriousmetabolism.substack.com/p/hearthealth
And thanks for making is #2 Overall Best-Selling in Science on Substack, Globally. That's heartening :).
But I’ll leave you with this: What is a consensus worth… when the status quo it represents has failed to meaningfully improve public health?